H.R.1862 - Regenerative Medicine Promotion Act of 2011

To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes.

The following letters were written by OpenCongress.org users and sent to their elected representatives. You can start a letter of your own by clicking the links to right.

Vote on This Bill

100% Users Support Bill

1 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC